Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Deuterated Drug Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112430187A reveals a novel SmI2-catalyzed reductive deuteration method for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.